Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Consultation on improving access to drugs and other health products in Canada Current status: Closed Opened on June 5, 2023, and closed to new input on August 31, 2023. A report summarising what we heard during the consultations was published in December 2023. Drugs and other…
Notice: Multiple additions to the Prescription Drug List (PDL) [2023-06-23] June 23, 2023 Our file number: 23-105485-620 The purpose of this Notice of Amendment is to notify about the addition of concizumab, daridorexant, foscarbidopa, foslevodopa, glofitamab, setmelanotide,…
Qualifying notice for Ondexxya Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-E251431 Control number: 266464 [employee name removed] [employee title removed] AstraZeneca…
Qualifying notice for Tecvayli Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e260336 Control number: 269369 [Employee name removed] [Employee title removed] Janssen Inc.…
L'équité, la diversité et l'inclusion dans le système de recherche Le Conseil de recherches en sciences humaines du Canada, le Conseil de recherches en sciences naturelles et en génie du Canada et les Instituts de recherche en santé du Canada sont déterminés à appuyer…
Consultation on draft guidance on preparing the product monograph in XML format: Closed consultation From: Health Canada Current Status: Closed This consultation ran from August 15, 2023, to November 5, 2023. The purpose of this consultation was to obtain feedback on the draft…
Notice: Multiple additions to the Prescription Drug List (PDL) [2023-08-30] August 30, 2023 Our file number: 23-107439-272 The purpose of this Notice of Amendment is to notify about the addition of andexanet alfa, cenobamate, clascoterone and phytomenadione (veterinary) to the…
Updates to the 2020 product monograph guidance and master template: Closed consultation From: Health Canada Current status: Closed This consultation ran from September 15, 2023, to November 13, 2023. Health Canada has revised the 2020 product monograph guidance and master…
Notice: Multiple additions to the Prescription Drug List (PDL) [2023-10-26] October 26, 2023 Our file number: 23-109746-618 The purpose of this Notice of Amendment is to notify about the addition of isoeugenol (veterinary), maralixibat, mirikizumab, somapacitan, teclistamab and…
Qualifying notice for Epkinly Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e262796 Control number: 271331 (Employee's name removed) (Employee's title removed) AbbVie…
Early release: coverage and features are still expanding.
